Search

everythinglearnresearchcommunity

for

Search:↓

Over half of the students had skin diseases, mainly foot issues and acne, with many unaware or untreated.

Nearly half of the studied men with long COVID had low testosterone, including younger men.

Almost half of the men with beard hair loss also developed scalp hair loss within a year.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Over half of patients had hair loss after weight-loss surgery, especially women, linked to low zinc and vitamin B12 levels.

Nearly half of women with PCOS have metabolic syndrome, and lifestyle changes are crucial to prevent complications.

About half of Taiwanese dermatologists use dermoscopy, mainly to improve diagnosis and detect cancer early, but cost and lack of training limit its wider use.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Over half of postmenopausal women experience hair loss, with severity increasing with age, time since menopause, and higher body mass index.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Over half of physiotherapy students in Lahore experience hair loss, highlighting the need for better education and early treatment.

Over half of alopecia areata patients in Tunisia experience depression, highlighting the need for psychological support.

Nearly half of the classification tools in the National Institute of Health and Clinical Excellence's Clinical Knowledge Summaries might not effectively guide management for general practitioners.

About half of people with mild alopecia areata see hair regrowth in a year, but relapses are common.

Over half of the dog skin disorders discussed have known gene variants, enabling genetic testing for diagnosis and responsible breeding.

Over half of the diabetes patients had skin issues, with fungal infections being most common.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

More than half of patients who had acromegaly surgery experienced hair loss, with varying degrees of recovery.

More than half of the women with PCOS in Southern India had Metabolic Syndrome, with large waist circumference being the most common feature.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Intravenous methylprednisolone helped over half of alopecia areata patients regrow hair, but many relapsed.

More than half of the young women checked had PCOS, which was linked to inactive lifestyles and poor diets.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Topical estrogens improved hair growth in about half of the patients.